Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Ohio Health Research Institute / Riverside Methodist Hospital
810
mi
from
Columbus, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Ohio Health Research Institute / Riverside Methodist Hospital
810
mi
from
Columbus, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Grady Memorial Hospital
810
mi
from
Delaware, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Grady Memorial Hospital
810
mi
from
Delaware, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Hematology Oncology Center
872
mi
from
Elyria, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Hematology Oncology Center
872
mi
from
Elyria, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Community Cancer Center
872
mi
from
Elyria, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Community Cancer Center
872
mi
from
Elyria, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Fairfield Medical Center
829
mi
from
Lancaster, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Fairfield Medical Center
829
mi
from
Lancaster, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Lima Memorial Hospital
762
mi
from
Lima, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Lima Memorial Hospital
762
mi
from
Lima, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Strecker Cancer Center at Marietta Memorial Hospital
890
mi
from
Marietta, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Strecker Cancer Center at Marietta Memorial Hospital
890
mi
from
Marietta, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Knox Community Hospital
841
mi
from
Mount Vernon, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Knox Community Hospital
841
mi
from
Mount Vernon, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Licking Memorial Cancer Care Program at Licking Memorial Hospital
843
mi
from
Newark, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Licking Memorial Cancer Care Program at Licking Memorial Hospital
843
mi
from
Newark, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Fisher-Titus Medical Center
845
mi
from
Norwalk, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Fisher-Titus Medical Center
845
mi
from
Norwalk, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Saint Charles Hospital
810
mi
from
Oregon, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Saint Charles Hospital
810
mi
from
Oregon, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
North Coast Cancer Care
842
mi
from
Sandusky, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
North Coast Cancer Care
842
mi
from
Sandusky, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Community Hospital of Springfield and Clark County
769
mi
from
Springfield, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Community Hospital of Springfield and Clark County
769
mi
from
Springfield, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Flower Hospital Cancer Center
796
mi
from
Sylvania, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Flower Hospital Cancer Center
796
mi
from
Sylvania, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Mercy Hospital of Tiffin
814
mi
from
Tiffin, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Mercy Hospital of Tiffin
814
mi
from
Tiffin, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Saint Anne's Hospital
1437
mi
from
Fall River, MA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Saint Anne's Hospital
1437
mi
from
Fall River, MA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
St. Vincent Mercy Children's Hospital
805
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
St. Vincent Mercy Children's Hospital
805
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Toledo Community Hospital Oncology Program CCOP
804
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Toledo Community Hospital Oncology Program CCOP
804
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Toledo Clinic Inc.
800
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Toledo Clinic Inc.
800
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
University of Toledo Medical Center
799
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
University of Toledo Medical Center
799
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Toledo Hospital
801
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Toledo Hospital
801
mi
from
Toledo, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Fulton County Health Center
772
mi
from
Wauseon, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Fulton County Health Center
772
mi
from
Wauseon, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Mount Carmel St. Ann's Cancer Center
816
mi
from
Westerville, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Mount Carmel St. Ann's Cancer Center
816
mi
from
Westerville, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Genesis Healthcare System
863
mi
from
Zanesville, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Genesis Healthcare System
863
mi
from
Zanesville, OH
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Bryn Mawr Hospital
1216
mi
from
Bryn Mawr, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Bryn Mawr Hospital
1216
mi
from
Bryn Mawr, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Paoli Memorial Hospital
1208
mi
from
Paoli, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Paoli Memorial Hospital
1208
mi
from
Paoli, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Reading Hospital & Medical Center
1187
mi
from
West Reading, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Reading Hospital & Medical Center
1187
mi
from
West Reading, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
CCOP - Main Line Health
1219
mi
from
Wynnewood, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
CCOP - Main Line Health
1219
mi
from
Wynnewood, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Lankenau Cancer Center at Lankenau Hospital
1219
mi
from
Wynnewood, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Lankenau Cancer Center at Lankenau Hospital
1219
mi
from
Wynnewood, PA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Cancer Centers of the Carolinas - Eastside
884
mi
from
Greenville, SC
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Eastside
884
mi
from
Greenville, SC
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Fredericksburg Oncology Inc
1106
mi
from
Fredericksburg, VA
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Fredericksburg Oncology Inc
1106
mi
from
Fredericksburg, VA
Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery
Laparoscopic Versus Robotic-Assisted Surgery for Rectal Cancer
Status: Archived
City of Hope Comprehensive Cancer Center
1152
mi
from
Duarte, CA
Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery
Laparoscopic Versus Robotic-Assisted Surgery for Rectal Cancer
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
1152
mi
from
Duarte, CA
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
A Phase II Clinical Trial of High Dose Vitamin D3 Supplementation in Combination With FOLFOX + Bevacizumab in the 1st Line Treatment of Metastatic Colorectal Cancer
Status: Archived
Roswell Park Cancer Center Institute
1054
mi
from
Buffalo, NY
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
A Phase II Clinical Trial of High Dose Vitamin D3 Supplementation in Combination With FOLFOX + Bevacizumab in the 1st Line Treatment of Metastatic Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Roswell Park Cancer Center Institute
1054
mi
from
Buffalo, NY
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase I Trial of Radioimmunotherapy (Y-90 M5A) in Combination With FOLFIRI and Bevacizumab Chemotherapy for Metastatic Colorectal Carcinoma
Status: Archived
City of Hope Medical Canter
1151
mi
from
Duarte, CA
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase I Trial of Radioimmunotherapy (Y-90 M5A) in Combination With FOLFIRI and Bevacizumab Chemotherapy for Metastatic Colorectal Carcinoma
Status: Archived
Updated: 1/1/1970
City of Hope Medical Canter
1151
mi
from
Duarte, CA
FLU-FIT Program at Kaiser Permanente Northern California
FLU-FIT Program at Kaiser Permanente Northern California
Status: Archived
Kaiser Permanente Northern California
1331
mi
from
Oakland, CA
FLU-FIT Program at Kaiser Permanente Northern California
FLU-FIT Program at Kaiser Permanente Northern California
Status: Archived
Updated: 1/1/1970
Kaiser Permanente Northern California
1331
mi
from
Oakland, CA
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin As Adjuvant Treatment After Resection Of Hepatic Metastases From Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
1263
mi
from
New Brunswick, NJ
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin As Adjuvant Treatment After Resection Of Hepatic Metastases From Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
1263
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin As Adjuvant Treatment After Resection Of Hepatic Metastases From Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin As Adjuvant Treatment After Resection Of Hepatic Metastases From Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Aurora Presbyterian Hospital
401
mi
from
Aurora, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Aurora Presbyterian Hospital
401
mi
from
Aurora, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Boulder Community Hospital
427
mi
from
Boulder, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Boulder Community Hospital
427
mi
from
Boulder, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Porter Adventist Hospital
407
mi
from
Denver, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Porter Adventist Hospital
407
mi
from
Denver, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Presbyterian - St. Luke's Medical Center
409
mi
from
Denver, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Presbyterian - St. Luke's Medical Center
409
mi
from
Denver, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
St. Anthony Central Hospital
411
mi
from
Denver, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
St. Anthony Central Hospital
411
mi
from
Denver, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Rose Medical Center
406
mi
from
Denver, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Rose Medical Center
406
mi
from
Denver, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
408
mi
from
Englewood, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
408
mi
from
Englewood, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
North Colorado Medical Center
411
mi
from
Greeley, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
North Colorado Medical Center
411
mi
from
Greeley, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Hope Cancer Care Center at Longmont United Hospital
425
mi
from
Longmont, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Hope Cancer Care Center at Longmont United Hospital
425
mi
from
Longmont, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
McKee Medical Center
433
mi
from
Loveland, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
McKee Medical Center
433
mi
from
Loveland, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
North Suburban Medical Center
410
mi
from
Thornton, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
North Suburban Medical Center
410
mi
from
Thornton, CO
Click here to add this to my saved trials
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Exempla Lutheran Medical Center
416
mi
from
Wheat Ridge, CO
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Exempla Lutheran Medical Center
416
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials